The pharmaceutical industry may be fighting a first-in-the-nation law in Nevada to demand pricing transparency on diabetes drugs, but Colorado legislator Dylan Roberts is not deterred.
Last week, he introduced a bill to similarly demand that drug makers report pricing histories, explain price hikes, disclose costs, and reveal the rebates paid to pharmacy benefit managers. And as in Nevada, he hopes the legislation will slow the cost of caring for diabetes. In Colorado, about $720 million, or 19 percent, of all diabetes care is spent on prescription drugs to control the disease, according to the bill.
“There are people who struggle every day to pay for a drug they need to survive,” Roberts told us. The legislation also would demand that pharmacy benefit managers disclose rebates received from drug makers.
About the Author Reprints
